The Botswana Medicines Regulatory Authority (BoMRA) was established by the Medicines and Related Substances Act of 2013. The Authority’s primary role is to administer the Medicines and Related Substances Act which is to regulate the supply chain of human and veterinary medicines, medical
devices, and cosmetics to ensure that they meet the set standards of safety quality and effectiveness.
Kindly be reminded that as previously advised in the stakeholder engagement and BoMRA communication of Ref: MRA 6/2/4 Vol. 1(98) , BoMRA has commenced licensing of schedule 4 and complementary medicines importers since January 2023.
Therefore, all Schedule 4 and complementary medicines are requested to submit applications for licensing before 1st of April 2023 in order to align with Section 28 of the Medicines and Related Substances Act, 2013.
From thereon issuance of all import/export permits to non-licensed entities will cease and enforcement actions will be initiated against all unlicensed importers. For further information please contact Tshupo Lekgwere at firstname.lastname@example.org or call +267 3731761